Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Journal of Viral Hepatitis|October 11, 2019
Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinomaYongbin Zeng, Shanjian Chen, Ya Fu, et al.Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|December 3, 2014
[Studies on the association of single nucleotide polymorphisms of HLA-DP and DQ genes with the outcome of chronic hepatitis B virus infection]Mingkuan Su, Yongbin Zeng, Jing Chen, et al.Frontiers in Endocrinology|April 29, 2026
Machine learning-based prediction of NAFLD in patients with type 2 diabetes using routine clinical and biochemical indicatorsYongjun Zeng, Jinlin Wang, Kun Lin, et al.Journal of Medical Virology|June 29, 2017
Association between mitochondrial DNA content and baseline serum levels of HBsAg in chronic hepatitis B infectionTianbin Chen, Zhen Xun, Jinpiao Lin, et al.Hepatology Communications|December 5, 2023
A genetic variant in the CD40 gene is related to HBV infection in the Chinese Han populationWennan Wu, Siyi Xu, Yongbin Zeng, et al.Plos One|March 4, 2014
Establishment of real time allele specific locked nucleic acid quantitative PCR for detection of HBV YIDD (ATT) mutation and evaluation of its applicationYongbin Zeng, Dezhong Li, Wei Wang, et al.Journal of Proteome Research|December 10, 2024
Multiomics Analyses Reveal that Fatty Acid Metabolism and TCA Cycle Contribute to the Achievement of Functional Cure in Chronic Hepatitis BKun Lin, Rongxian Qiu, Songhang Wu, et al.Journal of Medical Microbiology|January 18, 2015
Clinical significance of periodic detection of hepatitis B virus YVDD mutation by ultrasensitive real-time amplification refractory mutation system quantitative PCR during lamivudine treatment in patients with chronic hepatitis BYongbin Zeng, Bin Yang, Yingying Wu, et al.International Journal of Medical Sciences|July 7, 2020
The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks of Peg-IFNα-2b treatment aloneSheng Lin, Ya Fu, Wennan Wu, et al.Artificial Intelligence in Medicine|January 31, 2026
Double Graph Attention Network for predicting non-alcoholic fatty liver disease in patients with type 2 diabetesTianbin Chen, Yongbin Zeng, Jinlin Wang, et al.Pageof 5